The crosstalk between tumor cells and BMFs induced the upregulation of PD-L1 in BMFs by activating the Wnt/β-catenin signaling pathway in BMFs, which was abrogated by Wnt/β-catenin signaling inhibitors. This evidence concerns the gene CD274 and neoplasm.